Also categorized in Global Health:
Targeting the Type I Interferon Pathway to Treat Patients With Lupus
x hide permanently

Biomarkers to Identify SARS-CoV-2 Patients Requiring Invasive Mechanical Ventilation

Medical News

Photo: Horth Rasur/Shutterstock

In a recent study posted to the journal Biomolecules, researchers evaluated biomarkers that could help identify coronavirus disease 2019 (COVID-19) patients needing invasive mechanical ventilation (IMV).


COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared as a pandemic by the World Health Organization (WHO) in March 2020. There have been 460 million confirmed SARS-CoV-2 cases and more than six million COVID-19-related deaths so far globally.

Several SARS-CoV-2 patients with severe disease need IMV. However, many other COVID-19 patients require only supplemental oxygen via nasal cannula, i.e., non-invasive mechanical ventilation ...